596 results on '"Steffen, Björn"'
Search Results
2. Evaluation of a vaccination seminar in regard to medical students' attitudes and their theoretical and practical vaccination-specific competencies
3. Cytokine-responsive T- and NK-cells portray SARS-CoV-2 vaccine-responders and infection in multiple myeloma patients
4. The reliability and predictive validity of a sixth-semester OSPE in conservative dentistry regarding performance on the state examination
5. Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia
6. Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification
7. Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience
8. Treatment with midostaurin and other FLT3 targeting inhibitors is associated with an increased risk of cardiovascular adverse events in patients who underwent allogeneic hematopoietic stem cell transplantation with FLT3-mutated AML
9. Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry
10. Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial
11. Q-HAM: a multicenter upfront randomized phase II trial of quizartinib and high-dose Ara-C plus mitoxantrone in relapsed/refractory AML with FLT3-ITD
12. UBTF tandem duplications are rare but recurrent alterations in adult AML and associated with younger age, myelodysplasia, and inferior outcome
13. Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome
14. Diagnostic yield, indications, and outcomes of cranial imaging in AML patients admitted for intensive induction or consolidation chemotherapy: a single-center experience
15. Deep learning predicts therapy-relevant genetics in acute myeloid leukemia from Pappenheim-stained bone marrow smears
16. A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy
17. German Patient Blood Management Network: effectiveness and safety analysis in 1.2 million patients
18. A post hoc analysis of the EPAZ trial: The role of geriatric variables in elderly soft tissue sarcoma patients on toxicity and outcome
19. Relapse surveillance of acute myeloid leukemia patients in first remission after consolidation chemotherapy: diagnostic value of regular bone marrow aspirations
20. Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALL
21. UBTF::ATXN7L3 gene fusion defines novel B cell precursor ALL subtype with CDX2 expression and need for intensified treatment
22. Prognostic value of low-level MRD in adult acute lymphoblastic leukemia detected by low- and high-throughput methods
23. Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation
24. Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations
25. Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study
26. CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome
27. Fluid overload is associated with increased 90-day mortality in AML patients undergoing induction chemotherapy
28. Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial
29. Akute Leukämien
30. Autoreninnen und Autoren
31. No impact of time from diagnosis to treatment on survival in newly diagnosed AML treated with venetoclax-based regimens
32. Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial
33. Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia
34. Profiling of bacterial bloodstream infections in hematological and oncological patients based on a comparative survival analysis
35. Acute kidney injury adversely affects the clinical course of acute myeloid leukemia patients undergoing induction chemotherapy
36. Impact of Clostridioides difficile infection on the outcome of patients receiving a hematopoietic stem cell transplantation
37. Deep learning predicts therapy-relevant genetics in acute myeloid leukemia from Pappenheim-stained bone marrow smears
38. Cytokine-responsive T- and NK-cells portray SARS-CoV-2 vaccine-responders and infection in multiple myeloma patients
39. Use of carbapenems and glycopeptides increases risk for Clostridioides difficile infections in acute myeloid leukemia patients undergoing intensive induction chemotherapy
40. Low-dose melphalan in elderly patients with relapsed or refractory acute myeloid leukemia: A well-tolerated and effective treatment after hypomethylating-agent failure
41. PB2070: IMMUNE RESPONSES AFTER SARS-COV-2 MRNA-VACCINATION AND INFECTION AT SINGLE CELL RESOLUTION IN PATIENTS WITH MULTIPLE MYELOMA
42. P355: FAVORABLE OUTCOME OF PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA WITH IMATINIB, DOSE-REDUCED INDUCTION FOLLOWED BY ALLOGENEIC STEM CELL TRANSPLANTATION –RESULTS FROM THE GMALL TRIAL 08/13
43. S138: VALIDATION OF THE REVISED 2022 EUROPEAN LEUKEMIANET (ELN) RISK STRATIFICATION IN ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA
44. Bloodstream infections with vancomycin-resistant enterococci are associated with a decreased survival in patients with hematological diseases
45. Clinical and genetic characterization of de novo double-hit B cell precursor leukemia/lymphoma
46. Bloodstream infections with gram-negative organisms and the impact of multidrug resistance in patients with hematological malignancies
47. Kapitel 27 - Akute Leukämien
48. Specific Protein Redirection as a Transcriptional Therapy Approach for t(8;21) Leukemia
49. Das Konzept der Public-Key-Kryptographie
50. Komplexitätstheoretische Konzepte und eine neue Definition der Sicherheit
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.